ClinicalTrials.gg
Sign In

Biological

Pneumococcal 21-Valent Conjugate Vaccine clinical trials

Also written PCV21.

studies test it
19
open now
3
in phase 3
16
first study started
2019

Keep track of what changes. Save the Pneumococcal 21-Valent Conjugate Vaccine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

V116
11
Pneumococcal 21-valent Conjugate Vaccine
10
PCV21 vaccine
5
515
5
Polyvalent pneumococcal conjugate vaccine (pPCV)
2

Development codes

PCV21
3

Studies by the year they started

19 studies that test it; most in 2022 (6)

Studies that test Pneumococcal 21-Valent Conjugate Vaccine, by start year
YearStudies
20191
20211
20226
20232
20242
20254
20263

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
1
Phase 3
16
Phase 4
1

What it is tested for

Each study’s main condition, where its own words name it.

Pneumococcal Infections
9
Pneumonia, Pneumococcal
3
Anemia, Sickle Cell
1

Who runs them

Industry 18 · Other 1

Merck Sharp & Dohme LLC (11) · Sanofi (5) · Sanofi Pasteur, a Sanofi Company (2) · VA Sierra Nevada Health Care System (1)

Studies

Open first, then newest update. How each study uses Pneumococcal 21-Valent Conjugate Vaccine is read from its arms, and is right about nine times in ten.

Testing it · 19

Given in every arm · 1 — Pneumococcal 21-Valent Conjugate Vaccine is usual care beside what is tested
As the comparator · 1 — what is tested is compared with Pneumococcal 21-Valent Conjugate Vaccine